These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30627541)

  • 1. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer.
    Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
    Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma.
    Wu W; Miao L; Zhao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Wang Y; Jia T
    Hematology; 2024 Dec; 29(1):2293514. PubMed ID: 38108323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
    Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
    Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
    Mercier J; Voutsadakis IA
    J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
    Tan P; Chen J; Xie N; Xu H; Ai J; Xu H; Liu L; Yang L; Wei Q
    Cancer Med; 2018 Oct; 7(10):5096-5106. PubMed ID: 30151961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
    Basile D; Garattini SK; Corvaja C; Montico M; Cortiula F; Pelizzari G; Gerratana L; Audisio M; Lisanti C; Fanotto V; Ongaro E; Iacono D; Cardellino GG; Foltran L; Pella N; Buonadonna A; Aprile G; Di Maio M; Fasola G; Puglisi F
    Oncologist; 2020 Aug; 25(8):661-668. PubMed ID: 32202020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, Cancer Antigen 153 and Cancer Antigen 125 in Metastatic Breast Cancer.
    Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
    Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.
    Lisanti C; Basile D; Parnofiello A; Bertoli E; Andreotti VJ; Garattini SK; Bartoletti M; Cattaneo M; Di Nardo P; Bonotto M; Casagrande M; Da Ros L; Cinausero M; Foltran L; Pella N; Buonadonna A; Aprile G; Fasola G; Puglisi F
    J Geriatr Oncol; 2020 Nov; 11(8):1268-1273. PubMed ID: 32576519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
    Bigot F; Castanon E; Baldini C; Hollebecque A; Carmona A; Postel-Vinay S; Angevin E; Armand JP; Ribrag V; Aspeslagh S; Varga A; Bahleda R; Menis J; Gazzah A; Michot JM; Marabelle A; Soria JC; Massard C
    Eur J Cancer; 2017 Oct; 84():212-218. PubMed ID: 28826074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    Connell LC; Boucher TM; Chou JF; Capanu M; Maldonado S; Kemeny NE
    J Surg Oncol; 2017 Mar; 115(4):480-487. PubMed ID: 28008623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
    Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
    Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
    Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
    Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.
    Nissen NI; Kehlet S; Boisen MK; Liljefors M; Jensen C; Johansen AZ; Johansen JS; Erler JT; Karsdal M; Mortensen JH; Høye A; Willumsen N
    Sci Rep; 2021 Jan; 11(1):865. PubMed ID: 33441622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen.
    He WZ; Rong YM; Jiang C; Liao FX; Yin CX; Guo GF; Qiu HJ; Zhang B; Xia LP
    Chin J Cancer; 2016 Jun; 35(1):58. PubMed ID: 27357402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
    Liu R; Cao J; Gao X; Zhang J; Wang L; Wang B; Guo L; Hu X; Wang Z
    Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Shen J; Chen Z; Zhuang Q; Fan M; Ding T; Lu H; He X
    PLoS One; 2016; 11(11):e0166482. PubMed ID: 27861542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of thrombocytosis as predictive factor in colorectal cancer].
    Baranyai Z; Jósa V; Krzystanek M; Eklund AC; Szász AM; Szállási Z
    Magy Seb; 2013 Dec; 66(6):331-7. PubMed ID: 24333978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.